Pharmicell Co., Ltd. (KOSE: A005690)
Health Care · Biotechnology · KR
₩10,660.00
-10.50% today · -1.7% 1Y
Pharmicell Co., Ltd. (KOSE: A005690) operates in the Biotechnology industry within the Health Care sector. The company is valued at $461.54M.
Over the last twelve months the share price has lost 1.7%, trading between 8.14K and 21.15K.
Tweenvest scores Pharmicell Co., Ltd. across four factors: quality 28/100, value 68/100. Its strongest factor is value.
A005690 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $461.54M
- Revenue (TTM)
- $23.67M
- P/E
- —
- EPS
- -613.75
- Dividend yield
- —
- Beta (5Y)
- 0.63
- 52-week high
- ₩21,150.00
- 52-week low
- ₩8,140.00
- Avg volume (3M)
- —
- Shares outstanding
- 60.00M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $266.39 | +0.23% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.95 | -0.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.10 | -0.45% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.50 | -0.06% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €895.40 | +1.84% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $155.61 | -2.03% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.